{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:01:21Z","timestamp":1790233281929,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["16\/405"],"award-info":[{"award-number":["16\/405"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>M\u0101ori, Pacific and Asian women in New Zealand have lower cervical-cancer screening rates than European women, and there are persistent inequities in cervical cancer outcomes for M\u0101ori and Pacific women. Innovative ways to address access barriers are required. New Zealand is transitioning to screening with human papillomavirus (HPV) DNA testing, which could allow women themselves, rather than a clinician, to take the sample. Internationally, self-sampling has been found to increase screening participation rates. The aim of this open-label community-based randomised controlled trial is to investigate whether self-sampling increases screening participation among un- and under-screened M\u0101ori, Pacific and Asian women in New Zealand.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods\/design<\/jats:title><jats:p>We aim to invite at least 3550 un- or under-screened (\u22655\u2009years overdue) M\u0101ori, Pacific and Asian women (1050, 1250, 1250 respectively), aged 30\u201369\u2009years, for screening. The three study arms are: usual care in which women are invited to attend a clinic for a standard clinician-collected cytology test; clinic-based self-sampling in which women are invited to take a self-sample at their usual general practice; and mail-out self-sampling in which women are mailed a kit and invited to take a self-sample at home. Women will be randomised 3:3:1 to the clinic and mail-out self-sampling groups, and usual care. There is also a nested sub-study in which non-responding women in all allocation groups, when they subsequently present to the clinic for other reasons, are offered clinic or home-kit self-sampling. The primary outcome will be the proportion of women who participate (by taking a self-sample or cytology test).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This trial is the first to evaluate the effectiveness of mailed self-sampling in New Zealand and will be one of the first internationally to evaluate the effectiveness of opportunistic in-clinic invitations for self-sampling. The trial will provide robust evidence on the impact on participation proportions from different invitation approaches for HPV self-sampling in New Zealand un- and under-screened M\u0101ori, Pacific and Asian women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>ANZCTR Identifier: ACTRN12618000367246 (date registered 12\/3\/2018)<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=371741&amp;isReview=true;\">https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=371741&amp;isReview=true;<\/jats:ext-link>UTN: U1111\u20131189-0531.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12885-019-6401-y","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T15:03:13Z","timestamp":1575903793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened M\u0101ori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4159-3570","authenticated-orcid":false,"given":"Naomi","family":"Brewer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bartholomew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Wihongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collette","family":"Bromhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Crengle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Douwes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"6401_CR1","volume-title":"Unequal Impact II: M\u0101ori and non-M\u0101ori Cancer statistics by deprivation and rural\u2013urban status 2002\u20132006","author":"B Robson","year":"2010","unstructured":"Robson B, Purdie G, Cormack D. Unequal Impact II: M\u0101ori and non-M\u0101ori Cancer statistics by deprivation and rural\u2013urban status 2002\u20132006. Wellington: Te R\u014dp\u016b Rangahau Hauora a Eru P\u014dmare, University of Otago; 2010."},{"key":"6401_CR2","volume-title":"The New Zealand cervical Cancer audit report. Whakam\u0101tau mate Pukupuku Taiawa o Aotearoa. Screening of women with cervical Cancer, 2000\u20132002","author":"L Sadler","year":"2004","unstructured":"Sadler L, Priest P, Peters J, Crengle S, Jackson R. The New Zealand cervical Cancer audit report. Whakam\u0101tau mate Pukupuku Taiawa o Aotearoa. Screening of women with cervical Cancer, 2000\u20132002. Ministry of Health: Wellington; 2004."},{"key":"6401_CR3","volume-title":"National Cervical Screening Programme Annual Report 2015","author":"M Smith","year":"2018","unstructured":"Smith M, Rumlee L, Canfell K. National Cervical Screening Programme Annual Report 2015. National Screening Unit: Wellington; 2018."},{"key":"6401_CR4","volume-title":"\u2018Ala Mo\u2019ui: pathways to Pacific health and wellbeing 2010\u20132014","author":"Ministry of Health","year":"2010","unstructured":"Ministry of Health. \u2018Ala Mo\u2019ui: pathways to Pacific health and wellbeing 2010\u20132014. Wellington: Ministry of Health; 2010."},{"issue":"1","key":"6401_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/ije\/dyp303","volume":"39","author":"N Brewer","year":"2010","unstructured":"Brewer N, Pearce N, Jeffreys M, Borman B, Ellison-Loschmann L. Does screening history explain the ethnic differences in stage at diagnosis of cervical cancer in New Zealand? Int J Epidemiol. 2010;39(1):156\u201365.","journal-title":"Int J Epidemiol"},{"key":"6401_CR6","unstructured":"National Cervical Screening Programme Coverage Report. https:\/\/minhealthnz.shinyapps.io\/nsu-ncsp-coverage\/. Accessed 13 Aug 2019."},{"key":"6401_CR7","volume-title":"The report of the Committee of Inquiry into allegations concerning the treatment of cervical Cancer at National Women's hospital and into other related matters","author":"S Cartwright","year":"1988","unstructured":"Cartwright S. The report of the Committee of Inquiry into allegations concerning the treatment of cervical Cancer at National Women's hospital and into other related matters. Auckland: Government Printing Office; 1988."},{"issue":"4","key":"6401_CR8","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.7314\/APJCP.2015.16.4.1565","volume":"16","author":"S Foliaki","year":"2015","unstructured":"Foliaki S, Matheson A. Barriers to cervical screening among Pacific women in a New Zealand urban population. Asian Pac J Cancer Prev. 2015;16(4):1565\u201370.","journal-title":"Asian Pac J Cancer Prev"},{"key":"6401_CR9","volume-title":"An exploration of M\u0101ori health promotion within the National Cervical Screening Programme: a discussion document","author":"H Wihongi","year":"2000","unstructured":"Wihongi H. An exploration of M\u0101ori health promotion within the National Cervical Screening Programme: a discussion document. Health Funding Authority: Auckland; 2000."},{"issue":"1","key":"6401_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139.","journal-title":"J Pathol"},{"key":"6401_CR11","unstructured":"Castle PE. The new era of primary HPV screening for prevention of invasive cervical cancer. Cancer Forum. 2014;38(3):209\u201314."},{"key":"6401_CR12","volume-title":"Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: World Health Organization Press; 2013."},{"issue":"5","key":"6401_CR13","doi-asserted-by":"publisher","first-page":"E0151619","DOI":"10.1371\/journal.pone.0151619","volume":"11","author":"JB Lew","year":"2016","unstructured":"Lew JB, Simms K, Smith M, Lewis H, Neal H, Canfell K. Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand. PLoS One. 2016;11(5):E0151619.","journal-title":"PLoS One"},{"key":"6401_CR14","unstructured":"HPV vaccine. http:\/\/www.health.govt.nz\/our-work\/preventative-health-wellness\/immunisation\/hpv-immunisation-programme\/hpv-vaccine. Accessed 30 Jan 2017."},{"key":"6401_CR15","unstructured":"Ministry of Health. HPV immunisation coverage by ethnicity and eligible birth cohort. http:\/\/www.health.govt.nz\/our-work\/preventative-health-wellness\/immunisation\/hpv-immunisation-programme. Accessed 12 Sept 2019."},{"issue":"1","key":"6401_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/1471-2458-13-464","volume":"13","author":"L Camilloni","year":"2013","unstructured":"Camilloni L, Ferroni E, Cendales B, Pezzarossi A, Furnari G, Borgia P, Guasticchi G, Rossi P. Methods to increase participation Working Group. Methods to increase participation in organised screening programs: a systematic review. BMC Public Health. 2013;13(1):464.","journal-title":"BMC Public Health"},{"issue":"2","key":"6401_CR17","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/S2214-109X(14)70354-7","volume":"3","author":"S Arrossi","year":"2015","unstructured":"Arrossi S, Thouyaret L, Herrero R, Campanera A, Magdaleno A, Cuberli M, Barletta P, Laudi R, Orellana L. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial. Lancet Glob Health. 2015;3(2):e85\u201394.","journal-title":"Lancet Glob Health"},{"issue":"10","key":"6401_CR18","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/ijc.27790","volume":"132","author":"PJF Snijders","year":"2013","unstructured":"Snijders PJF, Verhoef VMJ, Arbyn M, Ogilvie G, Minozzi S, Banzi R, van Kemenade FJ, Heideman DAM, Meijer CJLM. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer. 2013;132(10):2223\u201336.","journal-title":"Int J Cancer"},{"issue":"2","key":"6401_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ijc.30031","volume":"139","author":"F Sultana","year":"2016","unstructured":"Sultana F, English DR, Simpson JA, Drennan KT, Mullins R, Brotherton JML, Wrede CD, Heley S, Saville M, Gertig DM. Home-based HPV self-sampling improves participation by never-screened and under-screened women: results from a large randomized trial (iPap) in Australia. Int J Cancer. 2016;139(2):281\u201390.","journal-title":"Int J Cancer"},{"issue":"4","key":"6401_CR20","doi-asserted-by":"publisher","first-page":"e0151979","DOI":"10.1371\/journal.pone.0151978","volume":"11","author":"E Enerly","year":"2016","unstructured":"Enerly E, Bonde J, Schee K, Pedersen H, L\u00f6nnberg S, Nyg\u00e5rd M. Self-sampling for human papillomavirus testing among non-attenders increases attendance to the Norwegian cervical Cancer screening Programme. PLoS One. 2016;11(4):e0151979.","journal-title":"PLoS One"},{"issue":"16","key":"6401_CR21","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.ejca.2015.07.006","volume":"51","author":"F Verdoodt","year":"2015","unstructured":"Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJF, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer. 2015;51(16):2375\u201385.","journal-title":"Eur J Cancer"},{"issue":"5","key":"6401_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5694\/mja16.00017","volume":"204","author":"A Farnsworth","year":"2016","unstructured":"Farnsworth A. Self-sampling HPV testing versus mainstream cervical screening and HPV testing. Med J Aust. 2016;204(5):171.","journal-title":"Med J Aust"},{"issue":"5","key":"6401_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1158\/1055-9965.EPI-14-1417","volume":"24","author":"M Arbyn","year":"2015","unstructured":"Arbyn M, Castle PE. Offering self-sampling kits for HPV testing to reach women who do not attend in the regular cervical cancer screening program. Cancer Epidemiol Biomark Prev. 2015;24(5):769\u201372.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"6401_CR24","unstructured":"The Capital Region of Denmark is at the forefront of the fight against cervical cancer with an HPV home test. https:\/\/www.regionh.dk\/english\/press-and-news\/latest-news\/Pages\/The-Capital-Region-of-Denmark-is-at-the-forefront-of-the-fight-against-cervical-cancer-with-an-HPV-home-test.aspx. Accessed 20 Mar 2017."},{"key":"6401_CR25","volume-title":"Sexually transmitted infections; summary of guidelines","author":"New Zealand Sexual Health Society","year":"2015","unstructured":"New Zealand Sexual Health Society. Sexually transmitted infections; summary of guidelines. Auckland: Sexually Transmitted Infection Education Foundation; 2015."},{"issue":"5","key":"6401_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1479-828X.2007.00768.x","volume":"47","author":"SB Rose","year":"2007","unstructured":"Rose SB, Lawton BA, Bromhead C, MacDonald EJ, Lund KA. Self-obtained vaginal swabs for PCR chlamydia testing: a practical alternative. Aust N Z J Obstet Gynaecol. 2007;47(5):415\u20138.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"6401_CR27","doi-asserted-by":"publisher","first-page":"k4823","DOI":"10.1136\/bmj.k4823","volume":"363","author":"M Arbyn","year":"2018","unstructured":"Arbyn M, Smith S, Temin S, Sultana F, Castle P, on behalf of the collaboration on self-sampling and HPV testing. Detecting cervical precancer and reaching underscreened women by using HPV testing on self-samples: updated meta-analyses. Brit Med J. 2018;363:k4823.","journal-title":"Brit Med J"},{"issue":"2","key":"6401_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","volume":"15","author":"M Arbyn","year":"2014","unstructured":"Arbyn M, Verdoodt F, Snijders P, Verhoef V, Suonio E, Dillner L, Minozzi S, Bellisario C, Banzi R, Zhao F-H, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014;15(2):172\u201383.","journal-title":"Lancet Oncol"},{"issue":"4","key":"6401_CR29","doi-asserted-by":"publisher","first-page":"e010660","DOI":"10.1136\/bmjopen-2015-010660","volume":"6","author":"G Stanczuk","year":"2016","unstructured":"Stanczuk G, Baxter G, Currie H, Lawrence J, Cuschieri K, Wilson A, Arbyn M. Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the papillomavirus Dumfries and Galloway-PaVDaG study). BMJ Open. 2016;6(4):e010660.","journal-title":"BMJ Open"},{"issue":"3","key":"6401_CR30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ijc.29026","volume":"136","author":"RP Bosgraaf","year":"2015","unstructured":"Bosgraaf RP, Verhoef VM, Massuger LF, Siebers AG, Bulten J, de Kuyper-de Ridder GM, Meijer CJ, Snijders PJ, Heideman DA. Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening. Int J Cancer. 2015;136(3):646\u201355.","journal-title":"Int J Cancer"},{"key":"6401_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jcv.2015.06.080","volume":"69","author":"F Sultana","year":"2015","unstructured":"Sultana F, Gertig DM, Wredec CD, Englisha DR, Simpson JA, Drennanb KT, Brotherton JM, Phillips G, Heley F, Castleg PE, et al. A pilot study to compare dry cervical sample collection with standard practice of wet cervical samples for human papillomavirus testing. J Clin Virol. 2015;69:210\u20133.","journal-title":"J Clin Virol"},{"issue":"2","key":"6401_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/sj.bjc.6606040","volume":"104","author":"P Giorgi Rossi","year":"2011","unstructured":"Giorgi Rossi P, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C, Di Pierro C, Grazzini G, Angeloni C, Capparucci P, et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer. 2011;104(2):248\u201354.","journal-title":"Br J Cancer"},{"issue":"5","key":"6401_CR33","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10900-014-9931-x","volume":"39","author":"K Galbraith","year":"2014","unstructured":"Galbraith K, Gilkey M, Smith J, Richman A, Barclay L, Brewer N. Perceptions of mailed HPV self-testing among women at higher risk for cervical Cancer. J Community Health. 2014;39(5):849\u201356.","journal-title":"J Community Health"},{"issue":"2","key":"6401_CR34","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1007\/BF03405681","volume":"104","author":"C Racey","year":"2013","unstructured":"Racey C, Withrow D, Gesink D. Self-collected HPV testing improves participation in cervical Cancer screening: a\u2008systematic review and meta-analysis. Can J Public Health. 2013;104(2):e159\u201366.","journal-title":"Can J Public Health"},{"key":"6401_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ajo.12933","volume":"59","author":"A Adcock","year":"2019","unstructured":"Adcock A, Cram F, Lawton B, Geller S, Hibma M, Sykes P, MacDonald E, Dallas-Katoa W, Rendle B, Cornell T, et al. Acceptability of self-taken vaginal HPV sample for cervical screening among an under-screened indigenous population. Aust N Z J Obstet Gynaecol. 2019;59:1\u20137.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1497","key":"6401_CR36","first-page":"21","volume":"132","author":"N Brewer","year":"2019","unstructured":"Brewer N, Foliaki S, Bromhead C, Viliamu-Amusia I, Pelefoti-Gibson L, Jones T, Pearce N, Potter J, Douwes J. Acceptability of human papillomavirus self-sampling for cervical-Cancer screening in under-screened M\u0101ori and Pasifika women: a pilot study. NZ Med J. 2019;132(1497):21\u201331.","journal-title":"NZ Med J"},{"key":"6401_CR37","volume-title":"Guidelines for cervical screening in New Zealand","author":"National Screening Unit","year":"2008","unstructured":"National Screening Unit. Guidelines for cervical screening in New Zealand. Wellington: Ministry of Health; 2008."},{"key":"6401_CR38","volume-title":"HISO 10001: 2017 ethnicity data protocols","author":"Ministry of Health","year":"2017","unstructured":"Ministry of Health. HISO 10001: 2017 ethnicity data protocols. Wellington: Ministry of Health; 2017."},{"issue":"2","key":"6401_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/0969141315573345","volume":"22","author":"A Lim","year":"2015","unstructured":"Lim A, Sasieni P. Consultation rates in cervical screening non-attenders: opportunities to increase screening uptake in GP primary care. J Med Screen. 2015;22(2):93\u20139.","journal-title":"J Med Screen"},{"key":"6401_CR40","unstructured":"National Screening Unit. Change of timing for improvements to the National Cervical Screening Programme. https:\/\/www.nsu.govt.nz\/news\/change-timing-improvements-national-cervical-screening-programme. Accessed 7 Mar 2019."},{"key":"6401_CR41","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ijc.21955","volume":"119","author":"J Cuzick","year":"2006","unstructured":"Cuzick J, Clavel C, Petry K-U, Meijer C, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, et al. Overview of the European and north American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119:1095\u2013101.","journal-title":"Int J Cancer"},{"key":"6401_CR42","unstructured":"Human papillomavirus (HPV) study. http:\/\/www.waitematadhb.govt.nz\/healthy-living\/hpv-study\/. Accessed 12 Sept 2019."},{"key":"6401_CR43","volume-title":"Process and outcome evaluation. A report prepared for the Waitemat\u0101 and Auckland District health boards","author":"G Martin","year":"2017","unstructured":"Martin G, Kaiwai H. For Wai research. Waitemat\u0101 and Auckland District health board human papilloma virus cervical screening self-sampling (HPV-SS) study in M\u0101ori women in West Auckland. In: Process and outcome evaluation. A report prepared for the Waitemat\u0101 and Auckland District health boards. Wai Research: Auckland; 2017."},{"issue":"4","key":"6401_CR44","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1071\/SH14236","volume":"12","author":"F Sultana","year":"2015","unstructured":"Sultana F, Mullins R, Murphy M, English DR, Simpson JA, Drennan KT, Heley S, Wrede CD, Brotherton JML, Saville M, et al. Women\u2019s views on human papillomavirus self-sampling: focus groups to assess acceptability, invitation letters and a test kit in the Australian setting. Sex Health. 2015;12(4):279\u201386.","journal-title":"Sex Health"},{"key":"6401_CR45","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1186\/s12885-015-1804-x","volume":"15","author":"F Sultana","year":"2015","unstructured":"Sultana F, Mullins R, English DR, Simpson JA, Drennan KT, Heley S, Wrede CD, Brotherton J, Saville M, Gertig DM. Women's experience with home-based self-sampling for human papillomavirus testing. BMC Cancer. 2015;15:849.","journal-title":"BMC Cancer"},{"key":"6401_CR46","volume-title":"National Cervical Screening Programme Policies and standards: section 5: providing a laboratory service","author":"Ministry of Health","year":"2015","unstructured":"Ministry of Health. National Cervical Screening Programme Policies and standards: section 5: providing a laboratory service. Wellington: Ministry of Health; 2015."},{"issue":"9","key":"6401_CR47","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","volume":"21","author":"M Arbyn","year":"2015","unstructured":"Arbyn M, Snijders PJ, Meijer CJ, Berkhof J, Cuschieri K, Kocjan BJ, Poljak M. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clin Microbiol Infect. 2015;21(9):817\u201326.","journal-title":"Clin Microbiol Infect"},{"key":"6401_CR48","volume-title":"Approval letter for the cobas HPV test, Roche","author":"US Food","year":"2011","unstructured":"Food US, Administration D. Approval letter for the cobas HPV test, Roche. US Food and Drug Administration: Silver Spring, MD; 2011."},{"key":"6401_CR49","unstructured":"Roche Molecular Systems Inc. The Netherlands is the first country to transition its national cervical cancer screening program from Pap to primary HPV screening. https:\/\/global.hpv16and18.com\/hcp\/netherlands-hpv-primary-screening.html. Accessed 1 Sept 2016."},{"key":"6401_CR50","volume-title":"National Cervical Screening Programme: Changing the primary laboratory test. Public consultation submission summary","author":"National Screening Unit","year":"2016","unstructured":"National Screening Unit. National Cervical Screening Programme: Changing the primary laboratory test. Public consultation submission summary. Wellington: Ministry of Health; 2016."},{"key":"6401_CR51","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1289\/ehp.6927","volume":"112","author":"N Pearce","year":"2004","unstructured":"Pearce N. Effect measures in prevalence studies. Environ Health Perspect. 2004;112:1047\u201350.","journal-title":"Environ Health Perspect"}],"updated-by":[{"DOI":"10.1186\/s12885-020-6671-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6401-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6401-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6401-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T09:30:16Z","timestamp":1722159016000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6401-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6401"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6401-y","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12885-020-6671-4","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"10 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Following publication of the original article [1], the authors reported an error in the authorship list associated with the paper. Georgina McPherson has therefore been added.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been granted ethics approval from the New Zealand Northern B Health and Disability Ethics Committee (reference: 17\/NTB\/120). Participants will give written informed consent, or consent will be assumed when a sample is received without a consent form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NB has been employed by a different university to assist with unrelated research funded by Janssen Cilag Ltd. CB has previously received education grants from Roche Diagnostics NZ and research funding from Hologic Australia. Roche Diagnostics NZ provided swabs and subsidised cobas HPV test kits for a pilot study carried out by NB, CB, JD and JP.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1198"}}